
CytomX Therapeutics Inc
NASDAQ:CTMX

Relative Value
The Relative Value of one
CTMX
stock under the Base Case scenario is
0.29
USD.
Compared to the current market price of 2.5 USD,
CytomX Therapeutics Inc
is
Overvalued by 89%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
